JOINT FILING AGREEMENT
Exhibit 99.1
This JOINT FILING AGREEMENT is entered into as of December 30, 2019, by and among the signatories hereto. The undersigned hereby agree that the
Statement on Schedule 13D with respect to the shares of Common Stock of Forte Biosciences, Inc., and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the
provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: August 1, 2022
|
Camac Partners, LLC
|
||
|
By: Camac Capital, LLC,
|
||
|
its general partner
|
||
|
By:
|
/s/ Xxxx Xxxxxxxxx
|
|
|
Xxxx Xxxxxxxxx
|
||
|
Managing Member of the XX
|
||
|
Xxxxx Capital, LLC
|
||
|
By:
|
/s/ Xxxx Xxxxxxxxx
|
|
|
Xxxx Xxxxxxxxx
|
||
|
Managing Member
|
||
|
By:
|
/s/ Xxxx Xxxxxxxxx
|
|
|
Xxxx Xxxxxxxxx
|
||
|
By: Camac Capital, LLC,
|
||
|
its general partner
|
||
|
By:
|
/s/ Xxxx Xxxxxxxxx
|
|
|
Name: Xxxx Xxxxxxxxx
|
||
|
Title: Managing Member of the GP
|
||
